Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Seagen Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$81.3 Billion
Q2 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$191.51 - $216.16 $1.67 Million - $1.88 Million	8,698 Added 13.58%	72,748 $15.4 Million
Q2 2023 Aug 09, 2023	BUY	$187.64 - $206.25 $664,057 - $729,918	3,539 Added 5.85%	64,050 $12.3 Million
Q1 2023 May 08, 2023	BUY	$127.59 - $203.08 $352,913 - $561,719	2,766 Added 4.79%	60,511 $12.3 Million
Q4 2022 Feb 07, 2023	BUY	$117.37 - $139.17 $742,599 - $880,528	6,327 Added 12.31%	57,745 $7.42 Million
Q3 2022 Nov 01, 2022	BUY	$135.27 - $180.11 $354,813 - $472,428	2,623 Added 5.38%	51,418 $7.04 Million
Q2 2022 Aug 04, 2022	BUY	$108.81 - $179.33 $326,865 - $538,707	3,004 Added 6.56%	48,795 $8.63 Million
Q1 2022 May 09, 2022	BUY	$119.61 - $157.85 $350,696 - $462,816	2,932 Added 6.84%	45,791 $6.6 Million
Q4 2021 Feb 07, 2022	BUY	$142.57 - $190.86 $993,000 - $1.33 Million	6,965 Added 19.4%	42,859 $6.77 Million
Q3 2021 Nov 04, 2021	BUY	$142.45 - $169.82 $200,284 - $238,766	1,406 Added 4.08%	35,894 $6.1 Million
Q2 2021 Aug 06, 2021	BUY	$135.08 - $161.1 $642,440 - $766,191	4,756 Added 16.0%	34,488 $5.45 Million
Q1 2021 May 06, 2021	BUY	$137.51 - $190.8 $641,896 - $890,654	4,668 Added 18.62%	29,732 $4.13 Million
Q4 2020 Feb 09, 2021	BUY	$164.63 - $211.93 $4.13 Million - $5.31 Million	25,064 New	25,064 $4.39 Million

Others Institutions Holding SGEN

# of Institutions

Shares Held

1.26M

Call Options Held

23K

Put Options Held

55.2K

View Full List

About Seagen Inc.

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

More about SGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account